Druey Kirk M, Parikh Samir M
Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Md.
Center for Vascular Biology Research and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
J Allergy Clin Immunol. 2017 Sep;140(3):663-670. doi: 10.1016/j.jaci.2016.10.042. Epub 2016 Dec 22.
In 1960, Dr Bayard Clarkson described a woman experiencing sporadic recurrent episodes of shock and anasarca. Plasma from an acute attack induced a shock-like syndrome when injected into rats. The enigmatic systemic capillary leak syndrome (SCLS) named for Dr Clarkson is characterized by transient and severe but reversible hemoconcentration and hypoalbuminemia caused by leakage of fluids and macromolecules into tissues. Although less than 500 cases of SCLS have been reported in the literature since 1960, the condition is probably underdiagnosed because of a lack of awareness and a high mortality without treatment. Allergists should be vigilant of this diagnosis because its presentation can resemble more common plasma leakage syndromes, including angioedema or systemic anaphylaxis. Although the precise molecular cause of SCLS remains unknown, substantial advances over the last 5 years have increased our understanding of SCLS pathogenesis.
1960年,贝亚德·克拉克森医生描述了一位患有间歇性反复休克和全身性水肿的女性。急性发作期的血浆注入大鼠体内时会诱发类似休克的综合征。以克拉克森医生命名的神秘的系统性毛细血管渗漏综合征(SCLS),其特征是液体和大分子渗入组织导致短暂、严重但可逆的血液浓缩和低白蛋白血症。自1960年以来,文献报道的SCLS病例不足500例,由于认识不足且未经治疗死亡率高,该病可能未得到充分诊断。过敏症专科医生应警惕这一诊断,因为其表现可能类似于更常见的血浆渗漏综合征,包括血管性水肿或全身性过敏反应。虽然SCLS的确切分子病因尚不清楚,但过去5年取得的重大进展增进了我们对SCLS发病机制的理解。